Skip to main content
Back
Watch Compare

Coherus Oncology, Inc.

Data quality: 83%
CHRS
Nasdaq Manufacturing Chemicals
$1.66
▼ $0.05 (-2.65%)
Mkt Cap: 248.07 M
Price
$1.66
Mkt Cap
248.07 M
Day Range
$1.61 — $1.70
52-Week Range
$0.71 — $2.62
Volume
787,617
Open $1.69
50D / 200D Avg
$1.83
9.71% below
50D / 200D Avg
$1.42
16.61% above

Quick Summary

Key Takeaways

Earnings grew 489.41% over the past year
ROE of 161.87% indicates high profitability
Negative free cash flow of -138.51 M
P/E of 1.48 — trading at a low valuation

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)489.41%
FCF Growth (3Y)N/A

Quality

Return on Equity
161.87%
Above sector avg (-53.41%)
ROIC-89.42%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.24
Interest Coverage-20.12

Valuation

PE (TTM)
1.48
Above sector avg (-1.48)
P/B Ratio2.83
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 1.5 -1.5
P/B 2.8 1.6
ROE % 161.9 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

EES logo EES WisdomTree U.S. SmallCap Fund
0.02% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) 489.41% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 168.02 M
ROE 161.87% ROA 35.15%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138.51 M
ROIC -89.42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.24
Interest Coverage -20.12 Asset Turnover N/A
Working Capital 88.66 M Tangible Book Value 67.15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 1.48 Forward P/E N/A
P/B Ratio 2.83 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55.84%
Market Cap 248.07 M Enterprise Value 144.72 M
Per Share
EPS (Diluted TTM) 1.43 Revenue / Share N/A
FCF / Share -0.92 OCF / Share -0.92
EPS CAGR (1Y) 472.00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -82.44%
SBC-Adj. FCF -159.56 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income 168.02 M 28.51 M -237.89 M -291.75 M -287.10 M
EPS (Diluted) 1.43 0.25 -2.53 -3.76 -3.81
Gross Profit — — — — —
Operating Income -181.13 M -111.67 M -203.20 M -256.88 M -263.86 M
EBITDA — — — — —
R&D Expenses 108.89 M 93.34 M 109.44 M 199.36 M 363.11 M
SG&A Expenses 100.60 M 167.74 M 192.02 M 198.48 M 169.71 M
D&A 1.30 M 1.80 M 3.20 M 3.70 M 3.45 M
Interest Expense 9.00 M 27.16 M 40.54 M 32.47 M 22.96 M
Income Tax 0.0 -380,000.0 -380,000.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 258.34 M 448.53 M 629.60 M 480.85 M 679.33 M
Total Liabilities 197.33 M 580.52 M 823.03 M 618.27 M 581.61 M
Shareholders' Equity 61.01 M -131.99 M -193.43 M -137.42 M 97.73 M
Total Debt — — — — —
Cash & Equivalents 88.88 M 125.99 M 102.89 M 63.55 M 417.20 M
Current Assets 206.71 M 341.58 M 475.63 M 381.23 M 602.32 M
Current Liabilities 140.39 M 282.98 M 331.77 M 138.69 M 165.33 M